Results of breast-conserving therapy for ductal carcinoma in situ: The Kyoto University experiences

被引：1

作者：

Kokubo M. ^{[1
]}

Mitsumori M. ^{[1
]}

Kanehira K. ^{[2
]}

Inamoto T. ^{[3
]}

Mise K. ^{[4
]}

Kodama H. ^{[4
]}

Yamabe H. ^{[2
]}

Hiraoka M. ^{[1
]}

机构：

[1] Department of Therapeutic Radiology and Oncology, Graduate School of Medicine, Kyoto University, Shogoin, Sakyo-ku, Kyoto 606-8507

[2] Gastroenterological Surgery, Graduate School of Medicine, Kyoto University

来源：

Breast Cancer | 2001年 / 8卷 / 2期

关键词：

BCT; Breast-conserving therapy; DCIS; Ductal carcinoma in situ; Radiation therapy;

D O I：

10.1007/BF02967495

中图分类号：

学科分类号：

摘要：

Background: The purpose of this study was to evaluate the results of breast-conserving therapy (BCT), defined as the combination of breast-conserving surgery with axillary dissection and definitive radiation therapy for ductal carcinoma in situ (DCIS). Methods: Between November 1987 and March 1998, 33 patients with DCIS undergoing BCT at our hospital were examined. The mean age was 48. All patients underwent quadrantectomy or wide excision as well as axillary dissection. Radiation therapy consisted of 50 Gy to the ipsilateral whole breast. Boost irradiation of 10 Gy was given to 15 patients with close or positive margins. Nearly all patients received adjuvant chemotherapy with 5-fluorouracil or its derivatives and adjuvant endocrine therapy with tamoxifen for 2 years. Results: The minimum and median follow-up periods were 32 and 80 months, respectively. All patients but one were followed. Only one patient had a non-invasive local recurrence, 23 months after her operation. This patient was salvaged with simple mastectomy. Her prognostic index score was 8. The five-year local control rate was 97%. No serious acute or late complications were noted. Conclusion: The results of this retrospective study substantiate favorable data and appear to confirm the efficacy and reasonable local recurrence rate of BCT for the treatment of DCIS.

引用

页码：153 / 157

页数：4

共 17 条

[1]

Mills J.M., Schultz D.J., Solin L.J., Preservation of cosmesis with low complication risk after conservative surgery and radiotherapy for ductal carcinoma in situ of the breast, International Journal of Radiation Oncology Biology Physics, 39, 3, pp. 637-641, (1997)

[2]

Silverstein M.J., Lagios M.D., Martino S., Lewinsky B.S., Craig P.H., Beron P.J., Gamagami P., Waisman J.R., Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast, Journal of Clinical Oncology, 16, 4, pp. 1367-1373, (1998)

[3]

Amichetti M., Caffo O., Richetti A., Zini G., Rigon A., Antonello M., Arcicasa M., Coghetto F., Valdagni R., Maluta S., Di Marco A., Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy, European Journal of Cancer, 33, 10, pp. 1559-1565, (1997)

[4]

Solin L.J., Kurtz J., Fourquet A., Amalric R., Recht A., Bornstein B.A., Kuske R., Taylor M., Barrett W., Fowble B., Haffty B., Schultz D.J., Yeh I.-T., McCormick B., McNeese M., Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast, Journal of Clinical Oncology, 14, 3, pp. 754-763, (1996)

[5]

Silverstein M.J., Lagios M.D., Craig P.H., Waisman J.R., Lewinsky B.S., Colburn W.J., Poller D.N., A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 11, pp. 2267-2274, (1996)

[6]

Silverstein M.J., Poller D.N., Waisman J.R., Et al., Prognostic classification of breast ductal carcinoma-in-situ, Lancet, 345, pp. 1154-1157, (1995)

[7]

Silverstein M.J., Barth A., Poller D.N., Et al., Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast, Eur J Cancer, 31 A, pp. 1425-1427, (1995)

[8]

Lagios M.D., Margolin F.R., Westdahl P.R., Rose M.R., Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence, Cancer, 63, 4, pp. 618-624, (1989)

[9]

Fisher B., Dignam J., Wolmark N., Mamounas E., Costantino J., Poller W., Fisher E.R., Wickerham D.L., Deutsch M., Margolese R., Dimitrov N., Kavanah M., Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B- 17, Journal of Clinical Oncology, 16, 2, pp. 441-452, (1998)

[10]

Fisher B., Dignam J., Wolmark N., Wickerham D.L., Fisher E.R., Mamounas E., Smith R., Begovic M., Dimitrov N.V., Margolese R.G., Kardinal C.G., Kavanah M.T., Fehrenbacher L., Oishi R.H., Tamoxifen in treatment of intraductal breast cancer: National surgical adjuvant breast and bowel project B-24 randomised controlled trial, Lancet, 353, 9169, pp. 1993-2000, (1999)

← 1 2 →